Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome

C. T. Yeh, Jui-Hsiang Tang, C. W. Hsu, Y. C. Chen, M. L. Chang, C. Y. Lin

Research output: Contribution to journalArticle

Abstract

The aim of this case control study was to investigate the clinical significance of hepatitis B virus nuclear core antigen (HBcAg) in young cirrhotic patients. Fifteen cirrhotic patients with nuclear HBcAg in the liver biopsies were included. Their clinicopathological parameters as well as the core gene sequences were compared with those of a sex- and age-matched (1 to 2) control group. The mean follow-up periods were 124 ± 80 and 102 ± 43 months, respectively. Expression of nuclear HBcAg in cirrhotic liver was significantly associated with higher aspartate aminotransferase levels (P = 0.001), alanine aminotransferase levels (P < 0.001), and alpha-fetoprotein levels (P = 0.002), as well as a shorter duration to develop hepatocellular carcinoma or liver decompensation (Kaplan-Meier method, P = 0.044). Sequence analysis revealed mutations on the nuclear localization signal (NLS) of core protein in five cirrhotic patients with nuclear HBcAg (Q171K in four and Q179K in one patients). Site-directed mutagenesis experiments demonstrated that both the Q171K and Q179K mutation enhanced nuclear localization of the core protein. In conclusion, expression of nuclear HBcAg in young cirrhotic patients was associated with more severe hepatitis activities as well as an unfavourable long-term outcome. Mutations on the NLS of core protein were selected in some patients with nuclear HBcAg.

Original languageEnglish
Pages (from-to)839-848
Number of pages10
JournalJournal of Viral Hepatitis
Volume15
Issue number11
DOIs
Publication statusPublished - Nov 1 2008
Externally publishedYes

Fingerprint

Nuclear Antigens
Hepatitis B virus
Nuclear Localization Signals
Mutation
Liver
Proteins
alpha-Fetoproteins
Aspartate Aminotransferases
Site-Directed Mutagenesis
Alanine Transaminase
Hepatitis
Sequence Analysis
Case-Control Studies
Hepatocellular Carcinoma
Biopsy
Control Groups
Genes

Keywords

  • Core antigen
  • Hepatitis B
  • Hepatocellular carcinoma
  • Nuclear localization signal
  • Viral mutant

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases
  • Virology

Cite this

Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome. / Yeh, C. T.; Tang, Jui-Hsiang; Hsu, C. W.; Chen, Y. C.; Chang, M. L.; Lin, C. Y.

In: Journal of Viral Hepatitis, Vol. 15, No. 11, 01.11.2008, p. 839-848.

Research output: Contribution to journalArticle

@article{3d0679658851482391161232588225fb,
title = "Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome",
abstract = "The aim of this case control study was to investigate the clinical significance of hepatitis B virus nuclear core antigen (HBcAg) in young cirrhotic patients. Fifteen cirrhotic patients with nuclear HBcAg in the liver biopsies were included. Their clinicopathological parameters as well as the core gene sequences were compared with those of a sex- and age-matched (1 to 2) control group. The mean follow-up periods were 124 ± 80 and 102 ± 43 months, respectively. Expression of nuclear HBcAg in cirrhotic liver was significantly associated with higher aspartate aminotransferase levels (P = 0.001), alanine aminotransferase levels (P < 0.001), and alpha-fetoprotein levels (P = 0.002), as well as a shorter duration to develop hepatocellular carcinoma or liver decompensation (Kaplan-Meier method, P = 0.044). Sequence analysis revealed mutations on the nuclear localization signal (NLS) of core protein in five cirrhotic patients with nuclear HBcAg (Q171K in four and Q179K in one patients). Site-directed mutagenesis experiments demonstrated that both the Q171K and Q179K mutation enhanced nuclear localization of the core protein. In conclusion, expression of nuclear HBcAg in young cirrhotic patients was associated with more severe hepatitis activities as well as an unfavourable long-term outcome. Mutations on the NLS of core protein were selected in some patients with nuclear HBcAg.",
keywords = "Core antigen, Hepatitis B, Hepatocellular carcinoma, Nuclear localization signal, Viral mutant",
author = "Yeh, {C. T.} and Jui-Hsiang Tang and Hsu, {C. W.} and Chen, {Y. C.} and Chang, {M. L.} and Lin, {C. Y.}",
year = "2008",
month = "11",
day = "1",
doi = "10.1111/j.1365-2893.2008.01017.x",
language = "English",
volume = "15",
pages = "839--848",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Expression of hepatitis B virus nuclear core antigen in young cirrhotic patients is associated with an unfavourable long-term outcome

AU - Yeh, C. T.

AU - Tang, Jui-Hsiang

AU - Hsu, C. W.

AU - Chen, Y. C.

AU - Chang, M. L.

AU - Lin, C. Y.

PY - 2008/11/1

Y1 - 2008/11/1

N2 - The aim of this case control study was to investigate the clinical significance of hepatitis B virus nuclear core antigen (HBcAg) in young cirrhotic patients. Fifteen cirrhotic patients with nuclear HBcAg in the liver biopsies were included. Their clinicopathological parameters as well as the core gene sequences were compared with those of a sex- and age-matched (1 to 2) control group. The mean follow-up periods were 124 ± 80 and 102 ± 43 months, respectively. Expression of nuclear HBcAg in cirrhotic liver was significantly associated with higher aspartate aminotransferase levels (P = 0.001), alanine aminotransferase levels (P < 0.001), and alpha-fetoprotein levels (P = 0.002), as well as a shorter duration to develop hepatocellular carcinoma or liver decompensation (Kaplan-Meier method, P = 0.044). Sequence analysis revealed mutations on the nuclear localization signal (NLS) of core protein in five cirrhotic patients with nuclear HBcAg (Q171K in four and Q179K in one patients). Site-directed mutagenesis experiments demonstrated that both the Q171K and Q179K mutation enhanced nuclear localization of the core protein. In conclusion, expression of nuclear HBcAg in young cirrhotic patients was associated with more severe hepatitis activities as well as an unfavourable long-term outcome. Mutations on the NLS of core protein were selected in some patients with nuclear HBcAg.

AB - The aim of this case control study was to investigate the clinical significance of hepatitis B virus nuclear core antigen (HBcAg) in young cirrhotic patients. Fifteen cirrhotic patients with nuclear HBcAg in the liver biopsies were included. Their clinicopathological parameters as well as the core gene sequences were compared with those of a sex- and age-matched (1 to 2) control group. The mean follow-up periods were 124 ± 80 and 102 ± 43 months, respectively. Expression of nuclear HBcAg in cirrhotic liver was significantly associated with higher aspartate aminotransferase levels (P = 0.001), alanine aminotransferase levels (P < 0.001), and alpha-fetoprotein levels (P = 0.002), as well as a shorter duration to develop hepatocellular carcinoma or liver decompensation (Kaplan-Meier method, P = 0.044). Sequence analysis revealed mutations on the nuclear localization signal (NLS) of core protein in five cirrhotic patients with nuclear HBcAg (Q171K in four and Q179K in one patients). Site-directed mutagenesis experiments demonstrated that both the Q171K and Q179K mutation enhanced nuclear localization of the core protein. In conclusion, expression of nuclear HBcAg in young cirrhotic patients was associated with more severe hepatitis activities as well as an unfavourable long-term outcome. Mutations on the NLS of core protein were selected in some patients with nuclear HBcAg.

KW - Core antigen

KW - Hepatitis B

KW - Hepatocellular carcinoma

KW - Nuclear localization signal

KW - Viral mutant

UR - http://www.scopus.com/inward/record.url?scp=54849424553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54849424553&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2893.2008.01017.x

DO - 10.1111/j.1365-2893.2008.01017.x

M3 - Article

VL - 15

SP - 839

EP - 848

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 11

ER -